ORIGINAL RESEARCH article
Front. Immunol., 23 June 2020
Sec. Inflammation
Volume 11 - 2020 | https://doi.org/10.3389/fimmu.2020.00907
RETRACTED: MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3
- JW
Jinpeng Wang 1
- PL
Ping Li 2
- XX
Xiaofei Xu 3
- BZ
Beilin Zhang 4
- JZ
Jing Zhang 1*
1. Department of Cardiology, The Second Hospital of Jilin University, Changchun, China
2. Department of Developmental Pediatrics, The Second Hospital of Jilin University, Changchun, China
3. Department of Radiology, The Second Hospital of Jilin University, Changchun, China
4. Department of Physiology, College of Basic Medical Sciences, Jilin University, Changchun, China
Summary
Citation
Wang J, Li P, Xu X, Zhang B and Zhang J (2020) RETRACTED: MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3. Front. Immunol. 11:907. doi: 10.3389/fimmu.2020.00907
Received
06 January 2020
Accepted
20 April 2020
Published
23 June 2020
Volume
11 - 2020
Edited by
Guochang Hu, University of Illinois at Chicago, United States
Reviewed by
Hongkuan Fan, Medical University of South Carolina, United States; Christine Noel Metz, Feinstein Institute for Medical Research, United States
Updates
This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.